113 related articles for article (PubMed ID: 30003753)
1. MiR-384 represses tumorigenesis by regulating CDK6 and predicts prognosis of clear cell renal cell carcinoma.
Guo L; Wang D; Zhang Z
J BUON; 2018; 23(3):787-794. PubMed ID: 30003753
[TBL] [Abstract][Full Text] [Related]
2.
Pan H; Hong Y; Yu B; Li L; Zhang X
Cancer Biother Radiopharm; 2019 Jun; 34(5):334-341. PubMed ID: 30844301
[No Abstract] [Full Text] [Related]
3. Up-regulation of miR-181a in clear cell renal cell carcinoma is associated with lower KLF6 expression, enhanced cell proliferation, accelerated cell cycle transition, and diminished apoptosis.
Lei Z; Ma X; Li H; Zhang Y; Gao Y; Fan Y; Li X; Chen L; Xie Y; Chen J; Wu S; Tang L; Zhang X
Urol Oncol; 2018 Mar; 36(3):93.e23-93.e37. PubMed ID: 29066014
[TBL] [Abstract][Full Text] [Related]
4. MiR-200c-3p inhibits cell migration and invasion of clear cell renal cell carcinoma via regulating SLC6A1.
Maolakuerban N; Azhati B; Tusong H; Abula A; Yasheng A; Xireyazidan A
Cancer Biol Ther; 2018 Apr; 19(4):282-291. PubMed ID: 29394133
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA ZFAS1 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-10a/SKA1 pathway.
Dong D; Mu Z; Wei N; Sun M; Wang W; Xin N; Shao Y; Zhao C
Biomed Pharmacother; 2019 Mar; 111():917-925. PubMed ID: 30841471
[TBL] [Abstract][Full Text] [Related]
6. LINC01426 contributes to clear cell renal cell carcinoma progression by modulating CTBP1/miR-423-5p/FOXM1 axis via interacting with IGF2BP1.
Jiang Y; Zhang H; Li W; Yan Y; Yao X; Gu W
J Cell Physiol; 2021 Jan; 236(1):427-439. PubMed ID: 32583425
[TBL] [Abstract][Full Text] [Related]
7. Downregulated miR-646 in clear cell renal carcinoma correlated with tumour metastasis by targeting the nin one binding protein (NOB1).
Li W; Liu M; Feng Y; Xu YF; Huang YF; Che JP; Wang GC; Yao XD; Zheng JH
Br J Cancer; 2014 Sep; 111(6):1188-200. PubMed ID: 25010867
[TBL] [Abstract][Full Text] [Related]
8. MiR-212-5p inhibits the malignant behavior of clear cell renal cell carcinoma cells by targeting TBX15.
Deng JH; Zheng GY; Li HZ; Ji ZG
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10699-10707. PubMed ID: 31858538
[TBL] [Abstract][Full Text] [Related]
9. miR-221-5p acts as an oncogene and predicts worse survival in patients of renal cell cancer.
Liu S; Wang Y; Li W; Yu S; Wen Z; Chen Z; Lin F
Biomed Pharmacother; 2019 Nov; 119():109406. PubMed ID: 31514066
[TBL] [Abstract][Full Text] [Related]
10. MiR-186 represses progression of renal cell cancer by directly targeting CDK6.
Guo Z; Lv X; Jia H
Hum Cell; 2020 Jul; 33(3):759-767. PubMed ID: 32266659
[TBL] [Abstract][Full Text] [Related]
11. MiR-337-3p suppresses the proliferation and metastasis of clear cell renal cell carcinoma cells via modulating Capn4.
Zhuang Q; Shen J; Chen Z; Zhang M; Fan M; Xue D; Lu H; Xu R; He X; Hou J
Cancer Biomark; 2018; 23(4):515-525. PubMed ID: 30452399
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-185 inhibits cell proliferation and induces cell apoptosis by targeting VEGFA directly in von Hippel-Lindau-inactivated clear cell renal cell carcinoma.
Ma X; Shen D; Li H; Zhang Y; Lv X; Huang Q; Gao Y; Li X; Gu L; Xiu S; Bao X; Duan J; Zhang X
Urol Oncol; 2015 Apr; 33(4):169.e1-11. PubMed ID: 25700976
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-29a inhibits proliferation and motility of schwannoma cells by targeting CDK6.
Ma J; Li T; Yuan H; Han X; Shui S; Guo D; Yan L
J Cell Biochem; 2018 Mar; 119(3):2617-2626. PubMed ID: 29023945
[TBL] [Abstract][Full Text] [Related]
14. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.
Xia B; Yang S; Liu T; Lou G
Mol Cancer; 2015 Mar; 14():57. PubMed ID: 25889927
[TBL] [Abstract][Full Text] [Related]
15. Propofol Disrupts Clear Cell Renal Cell Carcinoma Tumorigenesis by Regulating circFBXW7/miR-942 Axis.
Huang Y; Wu Y; Lu S
Nephron; 2022; 146(5):514-527. PubMed ID: 35307709
[TBL] [Abstract][Full Text] [Related]
16. miR-19a correlates with poor prognosis of clear cell renal cell carcinoma patients via promoting cell proliferation and suppressing PTEN/SMAD4 expression.
Ma Q; Peng Z; Wang L; Li Y; Wang K; Zheng J; Liang Z; Liu T
Int J Oncol; 2016 Dec; 49(6):2589-2599. PubMed ID: 27779660
[TBL] [Abstract][Full Text] [Related]
17. MiR-206 suppresses proliferation and epithelial-mesenchymal transition of renal cell carcinoma by inhibiting CDK6 expression.
Guo Z; Jia H; Ge J
Hum Cell; 2020 Jul; 33(3):750-758. PubMed ID: 32277426
[TBL] [Abstract][Full Text] [Related]
18. MiR-1 downregulation correlates with poor survival in clear cell renal cell carcinoma where it interferes with cell cycle regulation and metastasis.
Xiao H; Zeng J; Li H; Chen K; Yu G; Hu J; Tang K; Zhou H; Huang Q; Li A; Li Y; Ye Z; Wang J; Xu H
Oncotarget; 2015 May; 6(15):13201-15. PubMed ID: 26036633
[TBL] [Abstract][Full Text] [Related]
19. miR-566 functions as an oncogene and a potential biomarker for prognosis in renal cell carcinoma.
Pan X; Quan J; Li Z; Zhao L; Zhou L; Jinling X; Weijie X; Guan X; Li H; Yang S; Gui Y; Lai Y
Biomed Pharmacother; 2018 Jun; 102():718-727. PubMed ID: 29604591
[TBL] [Abstract][Full Text] [Related]
20. miR-663a inhibits tumor growth and invasion by regulating TGF-β1 in hepatocellular carcinoma.
Zhang C; Chen B; Jiao A; Li F; Sun N; Zhang G; Zhang J
BMC Cancer; 2018 Nov; 18(1):1179. PubMed ID: 30486878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
